Differential expression of circular RNAs in human umbilical cord mesenchymal stem cells treated with icariin

Xiaokun Liu,Xiaoqian Chu,Lingling Li,Shanshan Man,Li Wang,Yuhong Bian,Huifang Zhou
DOI: https://doi.org/10.1097/md.0000000000037549
IF: 1.6
2024-04-02
Medicine
Abstract:Human umbilical cord mesenchymal stem cells (hUMSCs), derived from Wharton's Jelly in human umbilical cord, have many advantages including multidirectional differentiation potential, low immunogenicity no ethical controversies, and vastly available source. [ 1 , 2 ] hUMSCs can differentiate into various types of cells, such as osteoblasts, adipocytes, chondrocytes, islet cells, nerve cells, cardiomyocytes, hepatocytes, germ cells, and so on. In recent years, hUMSCs have been used for treatment of a variety of disease, such as chronic liver injury [ 3 ] and renal failure. [ 4 ] However, apoptosis, low differentiation rate and low migration rate to damaged organs of transplanted cells limit the further application of hUMSCs. Therefore, improving the migration and differentiation ability, inhibiting apoptosis of transplanted cells might increase the efficacy of hUMSCs transplantation.
medicine, general & internal
What problem does this paper attempt to address?